Health care-associated pneumonia (HCAP): Empiric antibiotics targeting methicillin-resistant staphylococcus aureus (MRSA) and pseudomonas aeruginosa predict optimal outcome

Medicine

Volumn 90, Issue 6, 2011, Pages 390-395

  Micek, Scott T ^a   Reichley, Richard M ^b   Kollef, Marin H ^c  

^a BARNES JEWISH HOSPITAL   (United States)

^b BJC HEALTHCARE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER INFECTION; ADULT; ARTICLE; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MISSOURI; PNEUMONIA, STAPHYLOCOCCAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80755189021     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318239cf0a     Document Type: Article

References (27)

1. Al-Hasan MN, Wilson JW, Lahr BD, Thomsen KM, Eckel-Passow JE, Vetter EA, Tleyjeh IM, Baddour LM. A-Lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by Gram-negative bacilli. Antimicrob Agents Chemother. 2009;53:1386-1394.
2. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
3. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st centuryVa clinical super-challenge. N Engl J Med. 2009;360:439-443.
4. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12.
5. Carratala J, Mykietiuk A, Fernandez-Sabe N, Suarez C, Dorca J, Verdaguer R, Manresa F, Gudiol F. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393-1399. (Pubitemid 47052438)
6. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement. M100-S17. Wayne, PA: CLSI; 2007.
7. Dhainaut JF, Laterre PF, LaRosa SP, Levy H, Garber GE, Heiselman D, Kinasewitz GT, Light RB, Morris P, Schein R, Sollet JP, Bates BM, Utterback BG, Maki D. The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results. Crit Care Med. 2003;31:2291-2301. (Pubitemid 37100831)
8. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27:355-362. (Pubitemid 32249978)
9. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010;10:279-287.
10. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Perez XL, Sirvent JM, Edusepsis Study Group. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861-866.
11. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742-2751. (Pubitemid 38010630)
12. Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2008;47:S3-S13.
13. Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE Jr, Micek ST, Niederman MS, Ost D, Paterson DL, Segreti J. Healthcare-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomesVproceedings of the HCAP summit. Clin Infect Dis. 2008;46:S296YS334. (Pubitemid 351590141)
14. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-474. (Pubitemid 29083057)
15. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-3862. (Pubitemid 43062645)
16. Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH. A comparison of culture-positive and culture-negative healthcare-associated pneumonia. Chest. 2009;137:1130-1137.
17. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG, Infectious Diseases Society of America, American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27YS72. (Pubitemid 46290553)
18. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51:3568-3573. (Pubitemid 47519345)
19. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; 12th Informational Supplement. M100-S12. Wayne, PA: NCCLS; 2002.
20. Rello J, Lujan M, Gallego M, Valles J, Belmonte Y, Fontanals D, Diaz E, Lisboa T, PROCORNEU Study Group. Why mortality is increased in healthcare-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest. 2010;137:1138-1144.
21. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest. 2010;137:1283-1288.
22. Seymann GB, Di Francesco L, Sharpe B, Rohde J, Fedullo P, Schneir A, Fee C, Chan KM, Fatehi P, Dam TT. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis. 2009;49:1868-1874.
23. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135:633-640.
24. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for healthcare-associated pneumonia. Arch Intern Med. 2008;168:2205-2210.
25. Venditti M, Falcone M, Corrao S, Licata G, Serra P, Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150:19-26.
26. Webster D, Chui L, Tyrrell GJ, Marrie TJ. Healthcare-associated Staphylococcus aureus pneumonia. Can J Infect Dis Med Microbiol. 2007;18:181-188.
27. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with healthcare-associated pneumonia: a single-center experience. Chest. 2008;134:963-968.